Advertisement

Topics

PlaqueTec Ltd. Company Profile

09:17 EDT 25th May 2018 | BioPortfolio


News Articles [2 Associated News Articles listed on BioPortfolio]

Personalizing prevention

PlaqueTec plans to bring precision medicine to cardiovascular prevention with a catheter technology that enables biomarker discovery.

PlaqueTec Data Presented at EAS Show Lack of Correlation between Localised Coronary Artery Inflammatory Biomarker Expression and Systemic Elevation of Biomarkers including hsCRP

Analysis of intracoronary blood samples obtained via PlaqueTec’s Liquid Biopsy System suggests coronary inflammation may be independent of systemic inflammatory biomarkers ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Study of the Vascular Response to Percutaneous Coronary Intervention in Patients With Non-ST-elevation Acute Coronary Syndromes Using Intravascular Blood Sampling

This interventional study is using the PlaqueTec LBS will enrol participants already undergoing coronary angiography as a component of their standard care for NSTE-ACS. The study will invo...

More Information about "PlaqueTec Ltd." on BioPortfolio

We have published hundreds of PlaqueTec Ltd. news stories on BioPortfolio along with dozens of PlaqueTec Ltd. Clinical Trials and PubMed Articles about PlaqueTec Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PlaqueTec Ltd. Companies in our database. You can also find out about relevant PlaqueTec Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record